CPIX

Cumberland Pharmaceuticals

--(--)

Market Open: --

--(--)

Post-Market: --

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About CPIX

Cumberland Pharmaceuticals Inc.

The largest biopharmaceutical company in the Mid-South

Industry

Pharmaceutical

Established Date

Invalid Date

Listing Date

08/11/2009

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.cumberlandpharma.com

Security Type

Common stock

Office address

1600 West End Avenue, Suite 1300, Nashville, Tennessee 37203

Business

Introduction

Cumberland Pharmaceuticals Inc., was incorporated in 1999. Focusing on the acquisition, development and commercialization of branded prescription products, it is a growing specialty pharmaceutical company. The company's main target markets are acute care and gastrointestinal diseases in hospitals, which the company believes can effectively penetrate the relatively concentrated physician prescribing base through a relatively small, targeted sales force. The company is committed to providing innovative products that improve the quality of care for patients and address difficult medical requirements. The Company has product development and commercial capabilities and believes it can leverage its existing infrastructure to support its expected growth. The company's management team consists of veterans in the pharmaceutical industry. It has extensive experience in business development, product development, business and finance. The company's business development team identifies, evaluates and negotiates product acquisition, import licensing and export licensing opportunities. The company's product development team develops proprietary product formulations, manages its clinical trials, prepares all regulatory submissions and manages its medical call center. The company's high-quality and professional manufacturers oversee the production of its products. The company's marketing and sales professionals are responsible for its commercial activities, while the company works closely with third-party distribution partners to ensure availability and delivery of its products.

Company Financials

EPS

CPIX has released its 2024 Q4 earnings. EPS was reported at -0.02, versus the expected 0.00, missing expectations. The chart below visualizes how CPIX has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

CPIX has released its 2024 Q4 earnings report, with revenue of 10.44M, reflecting a YoY change of 11.57%, and net profit of -1.90M, showing a YoY change of 69.82%. The Sankey diagram below clearly presents CPIX’s revenue sources and cost distribution.